Abstract
Objectives
To identify prognostic factors affecting the clinical outcome in patients treated with rotator cuff ultrasound-guided percutaneous irrigation of calcific tendinopathy (US-PICT), by evaluating the degree of calcium removal, the size and consistency of calcific deposits, and baseline level of shoulder pain and functionality.
Methods
From January 2017 to December 2019, 79 patients (23 males, 56 females; mean age, 45.7 years) who underwent US-PICT were prospectively enrolled. The calcifications’ location, consistency, and size were evaluated. For US-PICT, local anesthesia, lavage of calcific material, and intrabursal steroid injection were performed. The degree of calcium removal was graded as total/partial. Shoulder pain and functionality were assessed with the visual analogue scale (VAS) in all and Constant score (CS) in a subset of patients, respectively, at 4 time-points. Mann-Whitney U test, Fisher’s test, and linear and binary logistic regression were utilized for analysis.
Results
Pain improvement correlated with the presence of larger calcifications and lower baseline VAS score, at 1 week (p = 0.001, p < 0.001, respectively) and 1 year (p < 0.001, p = 0.002, respectively). Improved functionality correlated with total calcification retrieval, higher baseline CS, and fluid/soft calcific consistency at 1 week (p = 0.013, p = 0.003, p = 0.019, respectively). Increased calcification size, cystic appearance, and lower baseline VAS scores independently predicted complete pain resolution at 1 year.
Conclusion
Large calcifications and low-grade pain at baseline correlated with short- and long-term pain improvement. The degree of calcium removal did not impact pain or functional improvement beyond 1 week. Increased calcification size, cystic appearance, and low-grade baseline pain predicted complete pain recovery at 1 year.
Key Points
• The presence of larger calcifications and lower-grade baseline pain appear to correlate with pain improvement at 1 week and 1 year after ultrasound-guided irrigation of rotator cuff calcific tendinopathy (US-PICT).
• Total calcification retrieval, less affected baseline shoulder functionality, and presence of fluid/soft consistency of calcific deposits appear to correlate with improved shoulder functionality at 1 week post-treatment.
• Baseline pain intensity and calcifications’ morphologic characteristics, but not the degree of calcium retrieval, represent predictors of complete pain recovery at 1 year after US-PICT.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Rotator cuff calcific tendinopathy (RCCT) represents a significant cause of shoulder pain, characterized by the deposition of calcium hydroxyapatite crystals on either inside of the rotator cuff (RC) tendons or in the peritendinous soft tissues, subacromial-subdeltoid bursa (SASD), and the underlying humeral head [1,2,3]. The critical zone of the supraspinatus tendon represents the most common target, while the disease may occur bilaterally in up to 25% of patients [4, 5]. RCCT is a common disorder with a reported prevalence of up to 7.8% in asymptomatic individuals and 42.5% in patients with subacromial pain syndrome, affecting mostly women aged between 30 and 60 years [6, 7]. Despite its benign and self-limiting nature, symptoms may vary from low-grade to intense and highly disabling pain, resistant to high doses of oral anti-inflammatory drugs, often associated with restriction of joint mobility [1, 7, 8].
No treatment is required for asymptomatic calcifications. Mild symptoms can be managed conservatively with physical therapy and oral anti-inflammatory drugs. For a subset of patients with RCCT refractory to conservative therapy, different treatment methods, including extra-corporeal shockwave therapy, subacromial steroid injections, ultrasound-guided percutaneous irrigation of calcific tendinopathy (US-PICT), and surgical removal of calcific deposits, are in use [9, 10].
Currently, although no gold standard has been established to treat RCCT, US-PICT is widely accepted as a first-line treatment with determined clinical effectiveness and superiority compared to subacromial steroid injections and extra-corporeal shockwave therapy, combined with a low complication rate [11,12,13,14,15,16,17]. The technical aspects, including the number, size, and positioning of the needle(s) as well as procedural details of the method, have been extensively studied [11,12,13,14]. However, to the best of our knowledge, there is scant and discordant literature regarding the factors affecting or predicting the treatment outcome. In this manner, there are conflicting reports about the relationship between satisfactory calcium removal and improved clinical outcome [4, 11, 18,19,20,21]. Additionally, small-sized calcific deposits, longer symptom duration, and requirement of repeated procedures have been proposed to represent factors denoting inferior outcomes, among others [20, 22, 23]. On the other hand, favorable initial response to US-PICT, larger size and softer calcification consistency, female gender, and younger age have been associated with success of the procedure [20, 22, 24].
Therefore, the aim of our study was to identify predictors of short- and long-term clinical outcomes in patients undergoing US-PICT for RCCT. For this purpose, (i) the degree of retrieved calcific material during US-PICT, (ii) the initial calcification size, (iii) the consistency of the calcific deposits at presentation, and (iv) the baseline level of pain and/or functionality were evaluated as possible predictors of treatment outcome.
Materials and methods
Patients
This study was conducted according to the principles of Helsinki Declaration in a university hospital and a district general hospital. Ethical committee approval was obtained together with written informed consent of all patients prior to each interventional procedure.
From January 2017 to December 2019, 195 consecutive patients who underwent US-PICT for painful RCCT were prospectively studied. All patients with ipsilateral partial/full-thickness RC tear (n = 19), painful shoulder pathology other than RCCT based on the diagnostic US examination and/or MRI (inflammatory arthritis, n = 4; adhesive capsulitis, n = 6), intraosseous or intrabursal extension of the calcific deposits confirmed by diagnostic US and/or MRI (n = 7), partially effective previous treatment with extracorporeal shockwave therapy (n = 5), physical therapy (n = 15), or local steroid injection (n = 38) during the last 3 months before inclusion; patients lost during follow-up (n = 6); and those with incomplete/failed US-PICT procedure (n = 16) were excluded (Fig. 1). Definition of treatment failure/non-completion is provided in “US-guided intervention.” The remaining 79 patients (23 males and 56 females; mean age, 45.7 years ± 7.88; range, 31–62 years) comprised our study population. Demographic data are shown in Table 1.
Diagnostic US examination
A diagnostic US evaluation of the affected shoulder, performed with a GE Logiq F8 ultrasound machine equipped with a 6–12-MHz probe, preceded all interventional procedures. All US examinations were performed according to the guidelines proposed by the European Society of Musculoskeletal Radiology by a single radiologist in each center (A.H.K. and E.E.V. with 34 and 7 years of experience in musculoskeletal imaging and intervention, respectively) [25, 26].
Tendons affected by RCCT were recorded and the consistency of calcific deposits was classified based on US appearance as (i) hard, when appearing as a hyperechoic rim causing posterior acoustic shadowing; (ii) soft, when depicted as a hyperechoic formation lacking posterior acoustic shadowing; and (iii) fluid, when presenting with a hypoechoic center, surrounded by a thin hyperechoic rim [18, 19] (Fig. 2). The maximum diameter of the calcific deposits was measured.
US-guided intervention
All interventional procedures were performed by the operators who conducted the corresponding diagnostic US examinations. Patients were placed in the supine position to avoid movement and prevent vagal reactions. The ipsilateral arm was laid along the body in neutral position or slight internal/external rotation.
The US-PICT procedure was performed based on a 3-step algorithm [13, 14, 18]:
-
1.
Probe preparation, skin antisepsis, and local anesthesia: A sterile probe cover was used and ordinary skin antisepsis was applied over the area of interest. For local anesthesia, up to 10 ml of 1% lidocaine hydrochloride was injected into the SASD bursa and around the calcifications, with a 23-gauge needle under continuous US guidance (Fig. 3).
-
2.
Aspiration of calcific material: Irrigation of calcific deposits was performed with a single-needle technique [14, 18]. In detail, by using an in-plane approach, an 18-gauge needle connected to a 10-ml syringe with 4 ml of NaCl 0.9% at room temperature was inserted into the center of the calcification, under constant sonographic monitoring. The calcification was hydrated by applying gentle and intermittent pressures on the syringe plunger, allowing the calcific material to reflux back in the syringe when the plunger was released. This step was repeated several times until the backflow saline was free of visible calcific material, with special attention given as not to disrupt the peripheral calcific rim. Gentle, rotational maneuvers of the needle or small adjustments of the needle tip location were occasionally performed to achieve an adequate washing circuit, in cases that aspiration was initially unsuccessful. A 23-gauge spinal needle was used to restore patency in cases of needle obstruction by calcific material [27]. The degree of aspirated calcific material at the end of the procedure was graded as either “total” or “partial” according to the absence or presence of measurable, residual calcification on US, apart from the thin, peripheral calcific rim, respectively (Fig. 4).
-
3.
Intrabursal steroid injection: At the end of the procedure, a 23-gauge needle was advanced into the SASD bursa, where 1 ml of triamcinolone 40 mg/ml was injected under US guidance for preventing the occurrence of post-procedural bursitis.
The US-PICT procedure was characterized as failed/non-completed when leakage of the injected saline was identified outside the calcification, after the initial compressions on the syringe plunger, implying disruption of its peripheral rim [14].
Following the completion of US-PICT, a thorough US examination of the shoulder was conducted to assess potential complications including tendinous rupture or acute hemorrhage. All patients were clinically observed for 30 min after the procedure by an experienced nurse and subsequently discharged with written information for management of potential short-term symptoms with oral painkillers (paracetamol up to 1000 mg for a maximum of 5 days post-procedure depending upon the presence of pain). Oral instructions to avoid shoulder overloading and intense exercise for 2 weeks following the injection were given to all patients. All patients were encouraged to provide us with all concerns regarding their treated shoulder during the timeframe of the study.
Clinical evaluation and follow-up
Clinical evaluation was performed for all patients, at baseline (pre-treatment) and during scheduled visits at 1 week, 1 month, 6 months, and 1 year after the treatment. Clinical examination at baseline was performed by two orthopedic surgeons (15 and 20 years of experience in shoulder pathologies) according to usual clinical practice and included definition of the level of pain, assessment of the active and passive shoulder range of motion, manual muscle and impingement testing (Hawkins-Kennedy or Neer impingement sign, arc test, and infraspinatus muscle strength test), cross-arm evaluation for acromioclavicular joint disease, and evidence of glenohumeral joint instability [28]. Clinical assessment at subsequent time points, including assessment of the active and passive shoulder range of motion and manual muscle testing, was performed by two musculoskeletal radiologists (34 and 7 years of experience) who were formally trained to perform clinical examination and assessment of the Constant score in an identical manner. All patients (n = 79) were evaluated with the use of a 10-cm visual analogue scale (VAS) for the assessment of pain [19]. VAS scores were assessed by the orthopedic surgeons at baseline and the musculoskeletal radiologists at subsequent time points. Part of the study group (n = 30) was assessed with the use of the Constant score (CS) for a multitude of parameters including activity level, shoulder pain, strength, and range of motion [29]. Complete resolution of symptoms was defined as a VAS score of 0 or 1, since the minimum clinically important difference in VAS score has been calculated to be 1.4 cm for patients with RC pathology [30].
Statistical analysis
Descriptive statistics were expressed as counts or mean ± standard deviation (SD) for categorical or continuous variables, respectively. Linear regression analysis was performed at all time-points to identify predictors significantly correlated with VAS and CS. Beta coefficients with their 95% confidence intervals were calculated for all variables included in the linear models, and R2 was used to assess model fit. At the final time-point (1 year), binary logistic regression was used to identify independent predictors of complete resolution of pain (VAS score 0 or 1 cm) at the end of the follow-up. Odds ratios and 95% confidence intervals of experiencing complete pain resolution were calculated for all clinical variables included in the model, and the Hosmer and Lemeshow test was utilized to assess goodness of fit. Two-group univariate comparisons were performed with the use of the Mann-Whitney U test for continuous or Fisher’s exact test for categorical variables. Statistical analysis was performed with SPSS v. 25 (IBM Corp.), and significance was defined at a p value < 0.05.
Results
Location of calcifications, consistency, and size
Calcific deposits were located in the supraspinatus, infraspinatus, and subscapularis tendon in 52, 10, and 4 patients, respectively, while they affected both supraspinatus and infraspinatus tendons in 13 patients (Table 1). These calcifications were classified as hard, soft, and fluid in 44, 27, and 8 patients, respectively, and were characterized by a mean maximum diameter of 12 mm (SD, 4.23; range, 6–22 mm).
Treatment results and follow-up
No significant complications occurred during the US-guided procedure or the immediate post-procedural period. Three patients (3.8%) complained of exacerbation of pain within the first 48 h following the intervention which resolved with oral painkiller drugs. Five patients (2 males, 3 females; mean age, 46.8 years) referred pain flare-up within 3 months after the procedure (mean time of pain recurrence, 86.6 days). A diagnostic US was subsequently performed which diagnosed subacromial bursitis, as distension of the SASD bursa larger than 2 mm, in all cases. Subsequently, these patients received a US-guided intrabursal injection of 1 ml of triamcinolone 40 mg/ml which resulted in complete pain resolution. Beyond the aforementioned cases, no other patient reported additional painkiller intake.
Retrieval of calcific material, ranging from partial to total, was possible in all patients as signified by the presence of solid or milky-like material in the syringe. Calcifications were totally aspirated in 49 patients (62%), leaving only a thin peripheral calcific rim depicted on US, and partially in 30 patients (38%), where US showed residual calcific deposits at the end of the treatment despite the backflow clear aspirate.
Linear regression analysis demonstrated that pain improvement (as assessed with VAS scores) was significantly correlated with the presence of larger calcifications and a lower baseline VAS score, at 1 week (p = 0.001, p < 0.001, respectively) and 1 year (p < 0.001, p = 0.002, respectively) after treatment. Importantly, the degree of calcification retrieval (total vs. partial) did not correlate with pain scores at any time-point (Table 2, Fig. 5). With regard to functionality improvement (based on CS), it was significantly correlated with total calcification retrieval (p = 0.013), higher baseline CS (p = 0.003), and the presence of fluid or soft calcifications (p = 0.019) only at 1 week post-treatment (Table 3).
A multivariable logistic regression model was built to identify the independent predictors of complete pain resolution at 1 year post-treatment. Specifically, the presence of large-sized calcifications at baseline was found to independently predict complete recovery of symptoms at 1 year (OR 1.2, 95% CI 1.039–1.42, p = 0.014), whereas higher baseline VAS scores were related to lower chances of complete pain resolution (OR 0.516, 95% CI 0.267–0.996, p = 0.049). The presence of fluid calcifications predicted complete resolution of symptoms compared to hard calcifications (OR 9.056, 95% CI 1.24–66.141, p = 0.03). Interestingly, the degree of calcific material retrieved during US-PICT did not impact symptom resolution at 1 year (p = 0.485) (Table 4).
Discussion
Herein, patients undergoing US-PICT for RCCT have been clinically evaluated over the course of 1 year and significant predictors of treatment outcomes have been identified. Importantly, the degree of retrieved calcific material did not appear to impact symptom remission, whereas large-sized baseline calcifications, a lower baseline VAS score, and the presence of fluid calcifications were identified as independent predictors of complete pain resolution at 1 year post-treatment. To the best of our knowledge, the worthlessness of maximal retrieval of calcifications has already been implied in the literature [4]. The present study comforts this finding by its prospective design.
The degree of retrieved calcific material during US-PICT did not have an impact on clinical outcome at 1 year and did not correlate with VAS scores at any time-point. Our finding challenges the common belief that US-PICT should achieve maximal extraction of the calcification [14]. The lack of relationship between post-treatment pain and the degree of calcium retrieval could be attributed to local bleeding and decompression of the calcium hydroxyapatite-containing cavity caused by the aspiration of even minimal calcific material or by dry-needling over the calcification, eventually leading to resorption of the remaining calcification and spontaneous healing [4, 10, 31, 32].
Complete arthroscopic removal of calcific material was previously found to lead to improved clinical outcome [33]. However, the follow-up time-point was set at 2 months post-arthroscopy, which, compared to our results, may imply a delayed clinical response of patients with partial removal of calcific material. This may be attributed to the inherent differences between the utilized methods, with US-PICT being less invasive compared to arthroscopic treatment.
In 38% of our patients, the degree of calcific material removal was graded as partial. Other studies on patients with RCCT treated with US-PICT report that all calcifications were mostly washed out at the end of the procedure [18, 19, 34]. Although these studies are oriented towards correlating the ease of calcium hydroxyapatite dissolution with clinical outcome rather than identifying predictors of complete symptom remission, the difference in effectiveness of calcific material removal could be explained by the utilization of room-temperature saline and single-needle technique in our study, instead of warm saline and double-needle technique.
Partial calcification retrieval was significantly correlated with a lower CS at 1 week post-treatment; however, it did not correlate with VAS scores at any time-point. Unlike the VAS scoring system, CS enables a holistic evaluation of functionality, including beyond shoulder pain, activity level, strength, and joint range of motion [29, 35]. Considering this inherent difference between the two scoring scales, the correlation between partial removal of calcific material and lower CS without correspondingly correlated VAS scores at 1 week may reflect the elimination of pain with persistent impaired shoulder functionality, by means of limited activity level, reduced strength, or restricted range of motion. This has also been reported by Rizzello et al who observed more substantial benefits in pain and external rotation than in activity level, range of motion, and strength, in the short term, after arthroscopic removal of calcific deposits [33]. This issue stresses the importance of careful selection and interpretation of the scoring scale, for both clinical and research purposes.
Regarding the size and consistency of the calcific deposits, identification of large and fluid calcifications at baseline predicted complete resolution of symptoms at 1 year. Existing data support a correlation between the presence of pain and increased size as well as cystic appearance of the calcific deposits, which may imply that these morphologic characteristics denote evolution of the calcifications into the highly symptomatic, resorptive phase [31, 36]. This, at least for patients with partial calcium removal, may explain our results by assuming that when performed during the resorptive phase, US-PICT may induce an accelerated and more effective auto-resorption process of the remaining calcific material. Our results regarding the correlation of long-term outcome with calcification size at baseline are in keeping with those provided by Oudelaar BW et al in their recent, interesting study [22].
Finally, baseline VAS scores served as an independent predictor of complete pain resolution, with higher scores at presentation being negatively related to symptom remission, defined as VAS score ≤ 1, at 1 year [30]. Considering that pain improvement after US-PICT, ranging between 17 and 80%, is changing proportionally with regard to the initial pain score, patients with lower baseline scores are more likely to achieve complete pain resolution post-treatment [11].
There are some limitations that should be considered in the present study. First, both diagnostic US and interventional procedures were performed by two different operators, which may have an impact on the evaluation of calcification characteristics and/or the amount of retrieved calcific material. However, both radiologists had received the same training regarding the performance of US-PICT. Second, two different scoring systems were utilized in the present study. Although CS was assessed in about half of patients, to our viewpoint, the comparative evaluation of the two scoring methods is adequately enabled. Third, the number of included patients may be regarded as a limitation. This is attributed to the application of strict inclusion criteria, which by themselves led to the exclusion of a large number of patients having a potential impact on the clinical applicability of our results. However, merely for research purposes, exclusion of patients with interfering causes of shoulder pain or impaired functionality ensured the homogeneity of the study group, by avoiding confounding effects. Finally, based on the study design implemented herein, a treatment algorithm for patients with RCCT having predictors of poor outcome for US-PICT, cannot be suggested. In this regard, further research in the context of randomized control trials comparing the efficacy of the method with alternative therapeutic options is required.
In conclusion, the morphologic characteristics of calcific deposits together with the pain/disability score at baseline may serve as predictors of clinical outcome following US-PICT. On the other hand, beyond the first week, the degree of extracted calcific material does not appear to show any prognostic significance or correlate with patients’ symptoms, implying that it is not essential to completely remove the calcified deposit in order to obtain substantial clinical benefit. Judging from the ongoing interest in the utilization of US-guided procedures around the shoulder, further research is needed in order to establish the predictors of clinical effectiveness for US-PICT in the long term. Determination of such prognostic factors, with potential impact on patient selection criteria and technical parameters, is important as it may allow for individualized management and can eventually further enhance the value of the method. Nonetheless, US-PICT largely remains the treatment of choice for painful rotator cuff calcific tendinopathy, with reported superiority over other non-surgical therapeutic options.
Abbreviations
- CS:
-
Constant score
- RC:
-
Rotator cuff
- RCCT:
-
Rotator cuff calcific tendinopathy
- SASD:
-
Subacromial-subdeltoid bursa
- SD:
-
Standard deviation
- US-PICT:
-
Ultrasound-guided percutaneous irrigation of calcific tendinopathy
- VAS:
-
Visual analogue scale
References
Speed CA, Hazleman BL (1999) Calcific tendinitis of the shoulder. N Engl J Med 340:1582–1584
Merolla G, Bhat MG, Paladini P, Porcellini G (2015) Complications of calcific tendinitis of the shoulder: a concise review. J Orthop Traumatol 16:175–183
Klontzas ME, Vassalou EE, Karantanas AH (2017) Calcific tendinopathy of the shoulder with intraosseous extension: outcomes of ultrasound-guided percutaneous irrigation. Skeletal Radiol 46:201–208
Uhthoff HK, Loehr JW (1997) Calcific tendinopathy of the rotator cuff: pathogenesis, diagnosis, and management. J Am Acad Orthop Surg 5:183–191
Gartner J, Heyer A (1995) Calcific tendinitis of the shoulder. Orthopade 24:284–302
Louwerens JK, Sierevelt IN, van Hove RP, van den Bekerom MP, van Noort A (2015) Prevalence of calcific deposits within the rotator cuff tendons in adults with and without subacromial pain syndrome: clinical and radiologic analysis of 1219 patients. J Shoulder Elbow Surg 24:1588–1593
Oliva F, Via AG, Maffulli N (2011) Calcific tendinopathy of the rotator cuff tendons. Sports Med Arthrosc Rev 19:237–243
Bureau NJ (2013) Calcific tendinopathy of the shoulder. Semin Musculoskelet Radiol 17:80–84
Sansone V, Maiorano E, Galluzzo A, Pascale V (2018) Calcific tendinopathy of the shoulder: clinical perspectives into the mechanisms, pathogenesis, and treatment. Orthop Res Rev 10:63–72
Chianca V, Albano D, Messina C et al (2018) Rotator cuff calcific tendinopathy: from diagnosis to treatment. Acta Biomed 89:186–196
Lanza E, Banfi G, Serafini G et al (2015) Ultrasound-guided percutaneous irrigation in rotator cuff calcific tendinopathy: what is the evidence? A systematic review with proposals for future reporting. Eur Radiol 25:2176–2183
Zhang T, Duan Y, Chen J, Chen X (2019) Efficacy of ultrasound-guided percutaneous lavage for rotator cuff calcific tendinopathy: a systematic review and meta-analysis. Medicine (Baltimore) 98:e15552
Messina C, Banfi G, Orlandi D et al (2016) Ultrasound-guided interventional procedures around the shoulder. Br J Radiol 89:20150372
Messina C, Sconfienza LM (2016) Ultrasound-guided percutaneous irrigation of calcific tendinopathy. Semin Musculoskelet Radiol 20:409–413
Sconfienza LM, Adriaensen M, Albano D et al (2020) Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)-part I, shoulder. Eur Radiol 30:903–913
Arirachakaran A, Boonard M, Yamaphai S, Prommahachai A, Kesprayura S, Kongtharvonskul J (2017) Extracorporeal shock wave therapy, ultrasound-guided percutaneous lavage, corticosteroid injection and combined treatment for the treatment of rotator cuff calcific tendinopathy: a network meta-analysis of RCTs. Eur J Orthop Surg Traumatol 27:381–390
Kim YS, Lee HJ, Kim YV, Kong CG (2014) Which method is more effective in treatment of calcific tendinitis in the shoulder? Prospective randomized comparison between ultrasound-guided needling and extracorporeal shock wave therapy. J Shoulder Elbow Surg 23:1640–1646
Orlandi D, Mauri G, Lacelli F et al (2017) Rotator cuff calcific tendinopathy: randomized comparison of US-guided percutaneous treatments by using one or two needles. Radiology 285:518–527.15
Sconfienza LM, Bandirali M, Serafini G et al (2012) Rotator cuff calcific tendinitis: does warm saline solution improve the short-term outcome of double-needle US-guided treatment? Radiology 262:560–566
Bazzocchi A, Pelotti P, Serraino S et al (2016) Ultrasound imaging-guided percutaneous treatment of rotator cuff calcific tendinitis: success in short-term outcome. Br J Radiol 89:20150407
del Cura JL, Torre I, Zabala R, Legórburu A (2007) Sonographically guided percutaneous needle lavage in calcific tendinitis of the shoulder: short- and long-term results. AJR Am J Roentgenol 189:W128–W134
Oudelaar BW, Huis In ‘t Veld R, Schepers-Bok R, Ooms EM, Nelissen RGHH, Vochteloo AJH (2020) Prognostic factors for the outcome of needle aspiration of calcific deposits for rotator cuff calcific tendinitis. Eur Radiol 30:4082–4090
de Witte PB, van Adrichem RA, Selten JW, Nagels J, Reijnierse M, Nelissen RG (2016) Radiological and clinical predictors of long-term outcome in rotator cuff calcific tendinitis. Eur Radiol 26:3401–3411
Pasquotti G, Faccinetto A, Marchioro U et al (2016) US-guided percutaneous treatment and physical therapy in rotator cuff calcific tendinopathy of the shoulder: outcome at 3 and 12 months. Eur Radiol 26:2819–2827
Beggs I, Bianchi S, Bueno A et al (2016) Musculoskeletal ultrasound technical guidelines. I. Shoulder. https://essr.org/content-essr/uploads/2016/10/shoulder.pdf
Martinoli C (2010) Musculoskeletal ultrasound: technical guidelines. Insights Imaging 1:99–141
Orlandi D, Fabbro E, Mauri G, Savarino E, Serafini G, Sconfienza LM (2013) RE: a simple technique to restore needle patency during percutaneous lavage and aspiration of calcific rotator cuff tendinopathy. PM R 5:633
Diercks R, Bron C, Dorrestijn O et al (2014) Guideline for diagnosis and treatment of subacromial pain syndrome: a multidisciplinary review by the Dutch Orthopaedic Association. Acta Orthop 85:314–322
Constant CR, Murley AH (1987) A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res 214:160–164
Tashjian RZ, Deloach J, Porucznik CA, Powell AP (2009) Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. J Shoulder Elbow Surg 18:927–932
Aina R, Cardinal E, Bureau NJ, Aubin B, Brassard P (2001) Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology 221:455–461
Bradley M, Bhamna MS, Robson MJ (1995) Ultrasound guided aspiration of symptomatic supratendinous calcific deposits. Br J Radiol 68:716–719
Rizzello G, Franceschi F, Longo UG et al (2009) Arthroscopic management of calcific tendinopathy of the shoulder–do we need to remove all the deposit? Bull NYU Hosp Jt Dis 67:330–333
Serafini G, Sconfienza LM, Lacelli F, Silvestri E, Aliprandi A, Sardanelli F (2009) Rotator cuff calcific tendonitis: short-term and 10-year outcomes after two-needle us-guided percutaneous treatment--nonrandomized controlled trial. Radiology 252:157–164
Kirkley A, Griffin S, Dainty K (2003) Scoring systems for the functional assessment of the shoulder. Arthroscopy 19:1109–1120
Chiou HJ, Hung SC, Lin SY, Wei YS, Li MJ (2010) Correlations among mineral components, progressive calcification process and clinical symptoms of calcific tendonitis. Rheumatology (Oxford) 49:548–555
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Prof. Apostolos H. Karantanas.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
One of the authors has significant statistical expertise.
Informed consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethical Approval
Institutional Review Board approval was obtained.
Methodology
• prospective
• diagnostic or prognostic study
• multicenter study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vassalou, E.E., Klontzas, M.E., Plagou, A.P. et al. Ultrasound-guided percutaneous irrigation of calcific tendinopathy: redefining predictors of treatment outcome. Eur Radiol 31, 2634–2643 (2021). https://doi.org/10.1007/s00330-020-07334-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-020-07334-2